The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: A cohort study

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 8, 2014, Pages 802-810

  Panara, A J ^a   Yarur, A J ^a   Rieders, B ^a   Proksell, S ^a   Deshpande, A R ^a   Abreu, M T ^a   Sussman, D A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DEPRESSIVE DISORDER; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84896397559     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12669     Document Type: Article

References (31)

1. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ,. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007; 13: 225-34.
2. Graff LA, Walker JR, Bernstein CN,. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009; 15: 1105-18.
3. Fuller-Thomson ESJ,. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006; 12: 697-707.
4. Mittermaier C, Dejaco C, Waldhoer T, et al,. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66: 79-84.
5. Kessler RC, Berglund P, Demler O, et al,. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2003; 289: 3095-105.
6. Kessler RC, Angermeyer M, Anthony JC,. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007; 6: 168-76.
7. Graff LA, Walker JR, Lix L,. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006; 4: 1491-501.
8. Häuser W, Janke KH, Klump B, Hinz A,. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011; 17: 621-32.
9. Sajadinejad MS, Asgari K, Molavi H, Kalantari M, Adibi P,. Psychological issues in inflammatory bowel disease: an overview. Gastroenterol Res Pract 2012; 2012: 106502.
10. Nahon S, Lahmek P, Durance C,. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2086-91.
11. Sutor B, Rummans TA, Jowsey SG, et al,. Major depression in medically ill patients. Mayo Clin Proc 1998; 73: 329-37.
12. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A): 5-36.
13. Wittchen HU, Kessler RC, Ustun TB,. Properties of the Composite International Diagnostic Interview (CIDI) for measuring mental health outcome. In:, Thornicroft G, Tansella M, eds, Mental Health Outcome Measures, 2nd ed. London: Gaskell, 2001; 212-27.
14. Norton S, Cosco T, Doyle F, Done J, Sacker A,. The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res 2013; 74: 74-81.
15. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE,. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
16. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE,. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-27.
17. Walker JR, Ediger JP, Graff LA, et al,. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008; 103: 1989-97.
18. Ananthakrishnan AN, Gainer VS, Cai T, et al,. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol 2013; 108: 594-601.
19. Hauser G, Tkalcic̈ M, Stimac D, Milic̈ S, Sincic̈ BM,. Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Coll Antropol 2011; 35: 203-7.
20. Porcelli P, Leoci C, Guerra V,. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996; 31: 792-6.
21. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES,. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97: 389-96.
22. Levenstein S, Prantera C, Varvo V, et al,. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994; 89: 1219-25.
23. Raison CL, Rutherford RE, Woolwine BJ, et al,. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression. JAMA Psychiatry 2013; 70: 31-41.
24. Guloksuz S, Wichers M, Kenis G, et al,. Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability. PLoS ONE 2013; 8: e60435.
25. Tanaka M, Kazuma K,. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 2005; 14: 65-73.
26. Vidal A, Gõmez-Gil E, Sans M, et al,. The impact of anxiety and depression on relapse in patients with inflammatory bowel disease. Med Clin (Barc) 2009; 132: 298-302.
27. Calvet X, Gallardo O, Coronas R, et al,. Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease. Inflamm Bowel Dis 2006; 12: 692-6.
28. Kunzendorf S, Jantschek G, Straubinger K, et al,. The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 33-41.
29. Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C,. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122: 913-21.
30. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, Craske MG, Stein MB,. Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the anxiety and depression detector. Gen Hosp Psychiatry 2006; 28: 108-18.
31. DiMatteo MR, Lepper HS, Croghan TW,. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 169: 2101-7.